Psychopharmacology and Psychiatry Updates

Faculty: Robert Hudak, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 1.25 CME: SSRI Dosing for OCD: Beyond FDA Guidelines
Treatment-Resistant OCD: From SSRIs to Augmentation

In this episode, we explore a new meta-analysis reconciling trazodone's real-world reputation with cautious sleep medicine guidelines, examining its effects on sleep architecture and depressive symptoms in patients with comorbid insomnia and depression, alongside its notable side effect profile. Can a decades-old antidepressant be the missing link for restorative sleep? 
Faculty: Paul Zarkowski, M.D.
Host: Flavio Guzmán, M.D.
Learn more about our memberships here
Earn 0.5 CMEs: Quick Take Vol. 85
Trazodone for Insomnia and Comorbid Depression: Are the AASM Guidelines Relevant?

In this episode, we explore why antipsychotics cause hyperprolactinemia and sexual side effects, a leading reason patients quietly stop treatment. Dr. Oliver Freudenreich breaks down which medications carry the highest risk, the long-term health implications, and practical strategies for monitoring, switching, or augmenting therapy.
Faculty: Oliver Freudenreich, M.D., F.A.C.L.P.
Host: Richard Seeber, M.D.
Learn more about our memberships here
Earn 1.25 CME: Managing Side Effects of Antipsychotics: What Every Psychiatrist Should Know
Managing Hyperprolactinemia and Sexual Side Effects from Antipsychotic Use

In this episode, we sit down with Dr. Oliver Freudenreich to unpack EMERGENT-5, the year-long trial tracking Cobenfy's real-world durability and safety in schizophrenia. We explore whether early symptom gains hold up over time, what side effects persist, and why blood pressure monitoring now deserves a permanent spot on your checklist.
Faculty: Oliver Freudenreich, M.D., F.A.C.L.P.
Host: Richard Seeber, M.D.
Learn more about our membership here
Earn 0.5 CME: Quick Take Vol. 85
Xanomeline-Trospium Long-Term: Does Efficacy and Safety Hold Up After One Year?

In this episode, we sit down with Dr. Oliver Freudenreich to unpack antipsychotic-induced weight gain — why it happens, which medications carry the highest risk, and how to build a proactive ABC strategy using switching, metformin, and emerging GLP-1 agonists to protect your patients' metabolic health. 
Faculty: Oliver Freudenreich, M.D., F.A.C.L.P.
Host: Richard Seeber, M.D.
Learn more about our memberships here
Earn 1.25 CME: Managing Side Effects of Antipsychotics: What Every Psychiatrist Should Know
Antipsychotic-Induced Weight Gain: Prevention and Management